Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1676.00 | 1644.00 | 1.0195 | 1.0416 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 1250.00 | 859.67 | 746.00 | 1644.00 | 0.4538 | -0.1407 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1705.00 | 1644.00 | 1.0371 | 1.0794 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 1584.00 | 1644.00 | 0.9635 | 0.9221 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 2093.00 | 1644.00 | 1.2731 | 1.5891 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 1250.00 | 859.67 | 758.00 | 1644.00 | 0.4611 | -0.1259 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 2053.00 | 1644.00 | 1.2488 | 1.5362 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 1330.00 | 1644.00 | 0.8090 | 0.5945 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 1250.00 | 859.67 | 895.00 | 1644.00 | 0.5444 | 0.0440 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1022.00 | 1644.00 | 0.6217 | 0.2031 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 1250.00 | 859.67 | 954.00 | 1644.00 | 0.5803 | 0.1178 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 859.67 | 819.00 | 1644.00 | 0.4982 | -0.0505 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 1250.00 | 859.67 | 1789.00 | 1644.00 | 1.0882 | 1.1891 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 1250.00 | 859.67 | 703.00 | 1644.00 | 0.4276 | -0.1935 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1740.00 | 1644.00 | 1.0584 | 1.1251 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1774.00 | 1644.00 | 1.0791 | 1.1695 | |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 1250.00 | 859.67 | 1331.00 | 1644.00 | 0.8096 | 0.5958 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 1250.00 | 859.67 | 997.00 | 1644.00 | 0.6065 | 0.1717 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1676.00 | 1644.00 | 1.0195 | 1.0416 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1449.00 | 1644.00 | 0.8814 | 0.7475 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1680.00 | 1644.00 | 1.0219 | 1.0469 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1707.00 | 1644.00 | 1.0383 | 1.0820 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 4.00 | 1644.00 | 0.0024 | -0.9968 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 4.00 | 1644.00 | 0.0024 | -0.9968 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1448.00 | 1644.00 | 0.8808 | 0.7462 |